IE36563B1 - New diazepine derivatives and processes for their production - Google Patents
New diazepine derivatives and processes for their productionInfo
- Publication number
- IE36563B1 IE36563B1 IE982/72A IE98272A IE36563B1 IE 36563 B1 IE36563 B1 IE 36563B1 IE 982/72 A IE982/72 A IE 982/72A IE 98272 A IE98272 A IE 98272A IE 36563 B1 IE36563 B1 IE 36563B1
- Authority
- IE
- Ireland
- Prior art keywords
- triazolo
- chloro
- methyl
- benzodiazepine
- methylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Compounds of the class of 2-(aminomethyl)-6-phenyl-4H-s-triazolo[1,5-a][1,4]benzodiazepines, their 5-oxides and the pharmaceutically acceptable acid addition salts of said compounds and their 5-oxides have valuable pharmacological properties, in particular anticonvulsant effectiveness, and are active ingredients for therapeutic preparations. Specific embodiments are 2-[(dimethylamino)-methyl]-6-phenyl-8-chloro-4H-s-triazolo[1,5-a][1,4] benzodiazepine, 2-[(methylamino)-methyl]-6-phenyl-8-chloro-4H-s-triazolo[1,5-a][1,4]be nzodiazepine, 2-[(dimethylamino)-methyl]-6-(o-fluorophenyl)-8-chloro-4H-s-triazolo[1 ,5-a][1,4]benzodiazepine, 2-[(methylamino)-methyl]-6-(o-fluorophenyl)-8-chloro-4H-s-triazolo[1,5 -a][1,4]benzodiazepine and 2-[(methylamino)-methyl]-6-(o-chlorophenyl)-8-chloro-4H-s-triazolo[1,5 -a][1,4]benzodiazepine.
[US3878205A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1088571A CH553801A (en) | 1971-07-23 | 1971-07-23 | PROCESS FOR THE PRODUCTION OF NEW DIAZEPIN DERIVATIVES. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE36563L IE36563L (en) | 1973-01-23 |
| IE36563B1 true IE36563B1 (en) | 1976-12-08 |
Family
ID=4367854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE982/72A IE36563B1 (en) | 1971-07-23 | 1972-07-12 | New diazepine derivatives and processes for their production |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US3878205A (en) |
| JP (1) | JPS561316B1 (en) |
| AR (2) | AR194603A1 (en) |
| AT (2) | AT319956B (en) |
| AU (1) | AU472145B2 (en) |
| BE (1) | BE786530A (en) |
| CA (1) | CA967956A (en) |
| CH (1) | CH553801A (en) |
| CS (2) | CS178411B2 (en) |
| DD (1) | DD99578A5 (en) |
| DE (1) | DE2234652A1 (en) |
| FI (1) | FI52729C (en) |
| FR (1) | FR2147092B1 (en) |
| GB (1) | GB1395416A (en) |
| HU (1) | HU165319B (en) |
| IE (1) | IE36563B1 (en) |
| IL (1) | IL39883A (en) |
| NL (1) | NL7209809A (en) |
| NO (1) | NO134868C (en) |
| PL (1) | PL85681B1 (en) |
| SE (1) | SE380804B (en) |
| SU (2) | SU472505A3 (en) |
| ZA (1) | ZA724839B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209516A (en) * | 1974-01-14 | 1980-06-24 | Ciba-Geigy Corporation | Triazole derivatives |
| JPS5747915B2 (en) * | 1974-04-17 | 1982-10-13 | ||
| US4209515A (en) * | 1974-06-14 | 1980-06-24 | Ciba-Geigy Corporation | Triazole derivatives |
| US3996230A (en) * | 1975-03-28 | 1976-12-07 | The Upjohn Company | 1-Piperazino-6-(2-pyridyl)-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
| US4510141A (en) * | 1982-09-13 | 1985-04-09 | Ciba-Geigy Corporation | Tricyclic polyazaheterocycles for treating depression or anxiety |
| CN118019742A (en) | 2021-09-29 | 2024-05-10 | 豪夫迈·罗氏有限公司 | Novel benzodiazepine derivatives as GABA Aγ1 PAM |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE758921A (en) * | 1969-11-15 | 1971-04-16 | Takeda Chemical Industries Ltd | BENZODIAZEPINE DERIVATIVES |
-
0
- BE BE786530D patent/BE786530A/en unknown
-
1971
- 1971-07-23 CH CH1088571A patent/CH553801A/en not_active IP Right Cessation
-
1972
- 1972-06-28 FI FI721828A patent/FI52729C/en active
- 1972-07-11 IL IL39883A patent/IL39883A/en unknown
- 1972-07-12 IE IE982/72A patent/IE36563B1/en unknown
- 1972-07-13 ZA ZA724839A patent/ZA724839B/en unknown
- 1972-07-13 SE SE7209242A patent/SE380804B/en unknown
- 1972-07-14 NL NL7209809A patent/NL7209809A/xx not_active Application Discontinuation
- 1972-07-14 DE DE2234652A patent/DE2234652A1/en active Pending
- 1972-07-14 US US272088A patent/US3878205A/en not_active Expired - Lifetime
- 1972-07-17 CA CA147,245A patent/CA967956A/en not_active Expired
- 1972-07-19 NO NO2588/72A patent/NO134868C/no unknown
- 1972-07-20 CS CS5172A patent/CS178411B2/cs unknown
- 1972-07-20 CS CS489A patent/CS178450B2/cs unknown
- 1972-07-21 FR FR7226331A patent/FR2147092B1/fr not_active Expired
- 1972-07-21 AT AT1013073A patent/AT319956B/en not_active IP Right Cessation
- 1972-07-21 AT AT631372A patent/AT318625B/en not_active IP Right Cessation
- 1972-07-21 DD DD164605A patent/DD99578A5/xx unknown
- 1972-07-21 SU SU1813891A patent/SU472505A3/en active
- 1972-07-21 GB GB3421672A patent/GB1395416A/en not_active Expired
- 1972-07-21 AU AU44837/72A patent/AU472145B2/en not_active Expired
- 1972-07-21 HU HUCI1256A patent/HU165319B/hu unknown
- 1972-07-21 PL PL1972156882A patent/PL85681B1/pl unknown
- 1972-07-22 JP JP7305972A patent/JPS561316B1/ja active Pending
- 1972-07-24 AR AR243233A patent/AR194603A1/en active
-
1973
- 1973-05-29 AR AR248269A patent/AR197989A1/en active
-
1974
- 1974-01-30 SU SU1993157A patent/SU497776A3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| FI52729C (en) | 1977-11-10 |
| DE2234652A1 (en) | 1973-02-01 |
| NL7209809A (en) | 1973-01-25 |
| IE36563L (en) | 1973-01-23 |
| FR2147092A1 (en) | 1973-03-09 |
| PL85681B1 (en) | 1976-04-30 |
| AT318625B (en) | 1974-11-11 |
| AU472145B2 (en) | 1976-05-20 |
| AR194603A1 (en) | 1973-07-31 |
| BE786530A (en) | 1973-01-22 |
| AR197989A1 (en) | 1974-05-24 |
| CH553801A (en) | 1974-09-13 |
| AU4483772A (en) | 1974-01-24 |
| SE380804B (en) | 1975-11-17 |
| SU472505A3 (en) | 1975-05-30 |
| CA967956A (en) | 1975-05-20 |
| NO134868C (en) | 1976-12-29 |
| US3878205A (en) | 1975-04-15 |
| CS178450B2 (en) | 1977-09-15 |
| ZA724839B (en) | 1973-04-25 |
| FI52729B (en) | 1977-08-01 |
| SU497776A3 (en) | 1975-12-30 |
| AT319956B (en) | 1975-01-27 |
| CS178411B2 (en) | 1977-09-15 |
| NO134868B (en) | 1976-09-20 |
| IL39883A (en) | 1976-06-30 |
| DD99578A5 (en) | 1973-08-12 |
| GB1395416A (en) | 1975-05-29 |
| IL39883A0 (en) | 1972-09-28 |
| JPS561316B1 (en) | 1981-01-13 |
| FR2147092B1 (en) | 1975-08-08 |
| HU165319B (en) | 1974-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69830503D1 (en) | TABLET WITH EXTENDED ACTIVE SUBSTANCE FOR THE TREATMENT OF PARKINSONTAL DISEASE | |
| GR3020396T3 (en) | Pharmaceutical formulation and process | |
| SE9502472L (en) | Cyclosporin composition based on an L2 phase | |
| HUT61311A (en) | Process for producing /1,2,4/triazolo/1,5-a//1,3,5/-traizine and pyrazolo/2,3-a//1,3,5/-triazine derivatives and pharmaceutical compositions comprising same as active ingredient | |
| FR2523582B1 (en) | NOVEL 1H-PYRAZOLO (1,5-A) SUBSTITUTED PYRIMIDINES, USEFUL IN PARTICULAR AS ANTI-INFLAMMATORY AND ANALGESIC DRUGS, AND PROCESS FOR THEIR PREPARATION | |
| NL7510620A (en) | PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE IMIDAZO (1,5-A) (1,4) DIAZEPINE COMPOUNDS. | |
| AU7425391A (en) | Use of n-alkylated 1, 4-dihydropyridinedicarboxylic acid esters as medicaments, new compounds and processes for their preparation | |
| IE36563B1 (en) | New diazepine derivatives and processes for their production | |
| IE37250B1 (en) | Diazepine derivatives and processes for their production | |
| IE35811B1 (en) | Diazepine derivatives and a process for their manufacture | |
| FI892684L (en) | Process for the preparation of therapeutically active 4-oxoimidazo/1,5-a/quinoxaline derivatives | |
| EP0255028A3 (en) | 1,4-Benzodiazepines, their preparation and use as PAF antagonists | |
| NO163228C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXADIAZOLYLIMIDAZOBENZODIAZEPIN CONNECTION. | |
| IE40267L (en) | Alkanolamine derivatives | |
| ATE45949T1 (en) | 4-ALKOXY-PYRIDO(2,3-D>PYRIMIDINE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICALS CONTAINING THEM. | |
| ZA787215B (en) | New amino derivatives of pyrazolo(1,5-a)s.triazine,processes for their preparation and their therapeutic applications | |
| RU94040865A (en) | Peptide derivatives and therapeutically acceptable salts thereof, process for preparation thereof, pharmaceutical composition having antiviral activity | |
| IL40043A (en) | 7-amino-5-phenyl-1,3-dihydro-1-alkoxyalkyl-2h-1,4-benzodiazepin-2-one derivatives,their preparation and pharmaceutical compositions containing them | |
| NO161563C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PYRAZOLO (1,5-A) PYRIDINE DERIVATIVES. | |
| IE810714L (en) | Process for erythromcylamine 11,12-carbonate | |
| GB1375806A (en) | ||
| CA2259449A1 (en) | Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction | |
| DE3372772D1 (en) | Quinazolinone derivatives, process for their preparation and their use in medicaments | |
| JPS6463521A (en) | Trapidyl-containing drug composition, manufacture and related therapeutical use | |
| HUP9901348A2 (en) | 2-[2-[(2-hydroxyethyl)amino]ethyl]-5-[[2-methylamino)ethyl]amino]indazolo[4,3-gh]isoquinolin-6(2h)-one as antitumor agent, use and production thereof, intermediates and medicaments containing the same |